LAURUSLABS vs RELIANCE
Head-to-head DCF comparison · Laurus Labs Limited vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 3 of 4model metrics · not investment advice
LAURUSLABS
Laurus Labs Limited
Pharma
₹1,131
Data LimitedRELIANCE
Reliance Industries
Oil & Gas
₹1,356
Fairly Valued| Metric | LAURUSLABS | RELIANCE |
|---|---|---|
| Verdict | Data Limited | Fairly Valued |
| YieldIQ Score | 40/100 | 48/100 |
| Fair Value | ₹415 | ₹1,266 |
| Current Price | ₹1,131 | ₹1,356 |
| Margin of Safety | -63.3% | -6.6% |
| Moat | Narrow | Narrow |
| Piotroski F-Score | 5/9 | 6/9 |
| ROE | 7.8% | 6.9% |
| Debt / Equity | — | — |
| EV / EBITDA | 39.0× | 14.3× |
| Market Cap | ₹0.61 Lakh Cr | ₹18.35 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.